MLSS
Milestone Scientific
NYSE MKT: MLSS · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$0.31
+0.00% today
Updated 2026-04-30
Market cap
$30.06M
P/E ratio
—
P/S ratio
3.35x
EPS (TTM)
$-0.07
Dividend yield
—
52W range
$0 – $1
Volume
2.5M
Milestone Scientific (MLSS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-63.80%
Operating margin
-52.50%
ROE
-132.40%
ROA
-40.50%
Debt/equity
0.41x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $5.84M | $-3.15M | 48.06% | -60.28% | -53.94% |
| 2007 | $6.39M | $-2.94M | 54.65% | -50.70% | -45.98% |
| 2008 | $6.62M | $-1.19M | 59.52% | -26.10% | -17.93% |
| 2009 | $8.55M | $-1.53M | 59.55% | -24.61% | -17.90% |
| 2010 | $9.75M | $-614508.00 | 63.78% | -7.19% | -6.30% |
| 2011 | $8.38M | $-1.48M | 63.99% | -14.60% | -17.69% |
| 2012 | $8.65M | $-870306.00 | 64.66% | -6.02% | -10.06% |
| 2013 | $10.01M | $1.46M | 68.05% | 10.85% | 14.63% |
| 2014 | $10.33M | $-1.70M | 64.86% | -7.65% | -16.47% |
| 2015 | $9.49M | $-5.47M | 67.88% | -32.20% | -57.60% |
| 2016 | $10.48M | $-5.95M | 60.16% | -62.14% | -56.73% |
| 2017 | $11.28M | $-5.19M | 61.77% | -46.40% | -45.97% |
| 2018 | $9.62M | $-7.43M | 46.05% | -83.14% | -77.24% |
| 2019 | $8.37M | $-7.52M | 68.28% | -47.75% | -89.85% |
| 2020 | $5.44M | $-7.34M | 66.60% | -137.08% | -134.94% |
| 2021 | $10.30M | $-6.82M | 61.25% | -71.60% | -66.17% |
| 2022 | $8.81M | $-8.71M | 55.65% | -100.24% | -98.87% |
| 2023 | $9.83M | $-6.93M | 69.12% | -72.31% | -70.51% |
| 2024 | $8.63M | $-4.71M | 74.56% | -78.30% | -54.62% |
| 2025 | $8.97M | $-5.72M | 71.40% | -63.48% | -63.76% |